Masimo Announces CE Marking of Pediatric Indication for Next Generation SedLine Brain Function Monitoring
NEUCHATEL, Switzerland--(BUSINESS WIRE)--Mar 4, 2019--Masimo (NASDAQ: MASI) announced today the CE marking of Next Generation SedLine brain function monitoring for pediatric patien…